SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:142531356"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:142531356" > Comprehensive detec...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Yellapantula, V (author)

Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019-12-11
  • Springer Science and Business Media LLC,2019

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:142531356
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142531356URI
  • https://doi.org/10.1038/s41408-019-0264-yDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Recent genomic research efforts in multiple myeloma have revealed clinically relevant molecular subgroups beyond conventional cytogenetic classifications. Implementing these advances in clinical trial design and in routine patient care requires a new generation of molecular diagnostic tools. Here, we present a custom capture next-generation sequencing (NGS) panel designed to identify rearrangements involving the IGH locus, arm level, and focal copy number aberrations, as well as frequently mutated genes in multiple myeloma in a single assay. We sequenced 154 patients with plasma cell disorders and performed a head-to-head comparison with the results from conventional clinical assays, i.e., fluorescent in situ hybridization (FISH) and single-nucleotide polymorphism (SNP) microarray. Our custom capture NGS panel had high sensitivity (>99%) and specificity (>99%) for detection of IGH translocations and relevant chromosomal gains and losses in multiple myeloma. In addition, the assay was able to capture novel genomic markers associated with poor outcome such as bi-allelic events involving TP53. In summary, we show that a multiple myeloma designed custom capture NGS panel can detect IGH translocations and CNAs with very high concordance in relation to FISH and SNP microarrays and importantly captures the most relevant and recurrent somatic mutations in multiple myeloma rendering this approach highly suitable for clinical application in the modern era.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hultcrantz, MKarolinska Institutet (author)
  • Rustad, EH (author)
  • Wasserman, E (author)
  • Londono, D (author)
  • Cimera, R (author)
  • Ciardiello, A (author)
  • Landau, H (author)
  • Akhlaghi, T (author)
  • Mailankody, S (author)
  • Patel, M (author)
  • Medina-Martinez, JS (author)
  • Ossa, JEA (author)
  • Levine, MF (author)
  • Bolli, N (author)
  • Maura, F (author)
  • Dogan, A (author)
  • Papaemmanuil, E (author)
  • Zhang, YM (author)
  • Landgren, O (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:Blood cancer journal: Springer Science and Business Media LLC9:12, s. 101-2044-5385

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view